We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+7.56%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$310B
AUM Growth
+$8.85B
Cap. Flow
-$12.9B
Cap. Flow %
-4.15%
Top 10 Hldgs %
14.55%
Holding
10,459
New
1,343
Increased
3,598
Reduced
4,167
Closed
928

Sector Composition

Rank Sector Weight
1 Technology 11.88%
2 Financials 7.38%
3 Consumer Discretionary 6.3%
4 Healthcare 6.09%
5 Communication Services 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JOF
7226
Japan Smaller Capitalization Fund
JOF
$348M
$22K ﹤0.01%
2,430
+373
+18% +$3.43K
LSF icon
7227
Laird Superfood
LSF
$50M
$22K ﹤0.01%
734
-839
-53% -$28.3K
LXFR icon
7228
Luxfer Holdings
LXFR
$457M
$22K ﹤0.01%
1,004
-1,240
-55% -$27K
MTR
7229
Mesa Royalty Trust
MTR
$5.33M
$22K ﹤0.01%
3,441
+2,941
+588% +$15.2K
FEED
7230
ENvue Medical Inc
FEED
$3.67M
$22K ﹤0.01%
12
-13
-52% -$26.3K
NERV icon
7231
Minerva Neurosciences
NERV
$207M
$22K ﹤0.01%
1,166
-2,086
-64% -$44.9K
THR
7232
DELISTED
Thermon Group Holdings
THR
$22K ﹤0.01%
1,309
-8,508
-87% -$158K
TTNP
7233
DELISTED
Titan Pharmaceuticals
TTNP
$22K ﹤0.01%
414
-759
-65% -$38K
ZDGE icon
7234
Zedge
ZDGE
$40.5M
$22K ﹤0.01%
1,181
+259
+28% +$3.62K
BNE
7235
DELISTED
Blue Horizon BNE ETF
BNE
$22K ﹤0.01%
765
-118
-13% -$3.3K
BNKD
7236
DELISTED
MicroSectorsTM U.S. Big Banks Index -3X Inverse Leveraged ETNs
BNKD
$22K ﹤0.01%
316
-437
-58% -$32.9K
MBTC
7237
DELISTED
Nocturne Acquisition Corporation Ordinary Shares
MBTC
$22K ﹤0.01%
+2,200
New +$21.7K
JHAA
7238
DELISTED
Nuveen Corporate Income 2023 Target Term Fund
JHAA
$22K ﹤0.01%
2,183
+167
+8% +$1.67K
LMNL
7239
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$22K ﹤0.01%
563
+562
+56,200% +$24.5K
MLAC
7240
DELISTED
Malacca Straits Acquisition Company Limited Class A Ordinary Shares
MLAC
$22K ﹤0.01%
2,199
+1,341
+156% +$13.3K
CYRN
7241
DELISTED
CYREN Ltd.
CYRN
$22K ﹤0.01%
1,365
+901
+194% +$12.3K
AHPI
7242
DELISTED
Allied Healthcare Products
AHPI
$22K ﹤0.01%
5,226
+1,864
+55% +$7.94K
HCICU
7243
DELISTED
Hennessy Capital Investment Corp. V Units
HCICU
$22K ﹤0.01%
2,087
-1,493
-42% -$15.3K
PV.U
7244
DELISTED
Primavera Capital Acquisition Corporation Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
PV.U
$22K ﹤0.01%
2,180
+1,171
+116% +$11.9K
VENAU
7245
DELISTED
Venus Acquisition Corporation Units
VENAU
$22K ﹤0.01%
+2,075
New +$22K
PAQCU
7246
DELISTED
Provident Acquisition Corp. Units
PAQCU
$22K ﹤0.01%
2,194
+1,935
+747% +$19.6K
RJI
7247
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Total Return
RJI
$22K ﹤0.01%
3,455
-3,447
-50% -$20.7K
RJZ
7248
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Metals Total Return
RJZ
$22K ﹤0.01%
1,958
-47
-2% -$524
PRPB
7249
DELISTED
CC Neuberger Principal Holdings II Class A Ordinary Shares
PRPB
$22K ﹤0.01%
2,250
-2,069
-48% -$20.5K
TVTY
7250
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$22K ﹤0.01%
834
-20,599
-96% -$517K

Similar funds

UBS Group's Q2 2021 Portfolio in Review

As of Q2 2021, UBS Group held 10,459 positions worth $310B, up 2.9% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

UBS Group withdrew a net $12.9B in Q2 2021, closing 928 positions and reducing 4,167 holdings. Its most notable exit was INPHI CORPORATION, an estimated $121M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, UBS Group opened a new position in Dimensional US Core Equity 2 ETF worth $42.4M.

  • UBS Group's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 1,571,036 shares worth $42.4M.
  • UBS Group added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $1.02B increase.
  • UBS Group's biggest Q2 2021 reduction was Alibaba, cutting an estimated $2.65B.
  • UBS Group fully exited INPHI CORPORATION in Q2 2021, selling an estimated $121M.
  • UBS Group's ten largest holdings make up 15% of its $310B portfolio in Q2 2021.
  • UBS Group opened 1,343 new positions and closed 928 in Q2 2021.
  • UBS Group's portfolio value rose 2.9% quarter-over-quarter to $310B.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.